Ongoing Clinical Trials

InPOG-LE-16-01- The Indian Childhood Cancer Survivorship Study (C2S study): After treatment completion registry of childhood cancers – Phase 1.

Principal Investigator: Dr. Rachna Seth

View Clinical Trial

InPOG-HL-17-02- Prospective Collaborative Study for Relapsed/Refractory Hodgkin Lymphoma.

Principal Investigator: Dr. Amita Mahajan

View Clinical Trial

InPOG-RARE-17-01- Clinical Course, Pathological Spectrum and Outcomes in Paediatric Rare Tumours in India: A Multicentric Observational Study.

Principal Investigator: Dr Maya Prasad

View Clinical Trial

InPOG-ALL-19-02- Registry study for relapsed childhood acute lymphoblastic leukaemia using protocol ALLR1.

Principal Investigator: Prof. Vaskar Saha

View Clinical Trial

InPOG-PNET-19-02 – Evaluation of clinic-pathological characteristics, prognostic factors and treatment outcomes in patients with ESFT in children and young adults.

Principal Investigator: Dr. Sandeep Jain

View Clinical Trial

InPOG-HIST-19-03- Prospective Collaborative Study for pulse dexamethasone and lenalidomide in Relapsed /Refractory Langerhans cell histiocytosis (LENDEX-LCH study).

Principal Investigator: Dr. Ramya Uppuluri

View Clinical Trial

INPHOG-AML-23-02- INDIAN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA Study (I-ChAMPs)

View Clinical Trial

InPOG-RB-17-01- A Prospective Collaborative Study for Newly Diagnosed patients with Retinoblastoma.

Principal Investigator: Dr. Santosh Honavar

View Clinical Trial

InPOG-HL-19-03- Response-Adapted Management of Childhood Classical Hodgkin Lymphoma (cHL) and Early Response Assessment by Positron Emission and Computerized Tomography (PET-CT) to allow Omission of Radiotherapy in Indian Children with Treated with a Standard of Care Intensified Chemotherapy Regimen.

Principal Investigator: Dr. Gaurav Narula

View Clinical Trial

INPHOG-SUPP-22-03- “Anti-Emetic Prophylaxis for Chemotherapy-Induced Vomiting Without Dexamethasone for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator- Initiated, Open-Label, Multi-Center, Non-Inferiority, Phase III Randomized Controlled Trial.

Principal Investigator: Dr. Venkatraman Radhakrishnan

View Clinical Trial

INPHOG-GCT-22-01- Integrated Clinico-pathological and treatment outcome analysis of extra-cranial malignant germ cell tumors in children and adolescents in India.

View Clinical Trial

INPHOG-EPI-22-03- ESTABLISHING THE FIRST DEDICATED POPULATION-BASED CHILDHOOD CANCER REGISTRY (PBCCR) AND NETWORK OF HOSPITAL-BASED CHILDHOOD CANCER REGISTRIES (HBCCRs) IN INDIA

View Clinical Trial